Heart disease is the cause of morbidity and mortality in the industrialized world. While the use of human induced pluripotent stem cell (iPSCs) in regenerative medicine is a long-term goal. Recent technological advancement has enabled the generation of patient-specific and disease-specific human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) in vitro. iPSC-CMs carry all the genetic information and therefore may be an ideal platform for elucidating disease modeling, drug screening, and cell therapy. Here I will discuss recent advances in this technology in the cardiovascular field.
Cardiac iPSCs for Drug Discovery
Video Apr 27, 2016
This brief video shows step by step how PerkinElmer Signals™ Screening automates HCS workflows. Powered by TIBCO Spotfire®, Signals Screening provides an embedded app store for easy access to common software tools for curve fitting, image analysis, and much more. Handle big data for faster, more efficient drug discovery. Plus easily share and re-use your experiments.WATCH NOW
The immune system is constantly on the lookout for threats, but cancer isn’t always easy to spot. Some cancer cells can fly under the radar. Now, advanced sequencing technologies are enabling scientists to investigate the unique genetics of both cancers and immune responses in individual patients. This means researchers can develop treatments that boost the immune system and help the body win its battle against cancer.WATCH NOW